Guest guest Posted August 3, 2004 Report Share Posted August 3, 2004 Greetings... There was an article on the front page of the boston globe's business & innovation section today (aug. 2) regarding a company called Elixir Pharmaceuticals (and another called Centagenetix, which recently merged with Elixir -- both are based in Cambridge) that is attempting to figure out why CR does what it does in hopes of creating a pill that will do the same thing. Apparently, the reality of scarce financial resources is causing the company to focus less on the core research (i.e., yeast and worm genes) and more on other pill ideas that could be brought to market -- and therefore reap profits for shareholders -- more quickly. It is an interesting article, worth searching for on the globe's website and reading for yourself. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.